The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients.

Osnat ElyashivNatalie AleohinZohar MigdanSophia LeytesOfri PeledOri Tal Tally Levy

Published in: Cancers (2024)

Platinum resistance is an important prognostic factor in women with EOC. Patients with SPR acquire the same poor treatment outcome as with PPR. There is a great need for future research efforts to discover novel strategies and biological treatments to reverse resistance and improve survival.

Keyphrases

prognostic factors
poor prognosis
long non coding rna
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
current status
quality improvement
free survival